Matt Kaeberlein: Dr. Matt Ranks Longevity Supplements: The Winners and Total Scams

🟢
Peer-Reviewed Research
M
Matt Kaeberlein

Video Summary · February 15, 2026

View Full Protocol →

Key Takeaways

  • Avoid fucoidin due to weak longevity evidence, extreme dosing requirements (50g/day), and potential heavy metal contamination.
  • Consider lithium orotate (not prescription lithium) for potential cognitive benefits based on consistent epidemiological and preclinical data.
  • Be skeptical of fisetin as a senolytic – mouse lifespan effects aren’t reproducible and human trial data remains weak.
  • Steer clear of anything marketed as “anti-aging” or “Sirtuin 6 activator” supplements.

Supplements & Protocols Mentioned

  • Fucoidin: Avoid (50g/day human equivalent dose is impractical)
  • Lithium orotate: Potential cognitive benefits (not prescription lithium carbonate)
  • Fisetin: Overhyped senolytic with unproven effects
  • Sirtuin 6 activators: Avoid all supplements making this claim

Notable Quotes

“Anything that is marketed under the term anti-aging goes in the avoid category.”

“The most overhyped longevity intervention ever.” (on NAD+ supplements)

Bottom Line

Focus on supplements with strong human evidence (like lithium orotate), avoid unproven “anti-aging” products, and be highly skeptical of mouse studies that don’t translate to practical human dosing.

Explore supplements mentioned in this video

Shop on iHerb →

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts